| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/14/2011 | US20110087012 Nucleic acid molecules coding for a protein with deacetylase activity, said protein, and method for the production of chitosan |
| 04/14/2011 | US20110087007 Cytokine-Like Proteins |
| 04/14/2011 | US20110087002 Methods for Cyclizing Synthetic Polymers |
| 04/14/2011 | US20110086905 Pseudocomplementary Oligonucleotides for Targeted Gene Therapy |
| 04/14/2011 | US20110086903 Emergence of a r-type ca2+ channel (cav 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage |
| 04/14/2011 | US20110086902 Compounds for the modulation of beta-catenin expression |
| 04/14/2011 | US20110086806 Polypeptides that Bind IL-23R |
| 04/14/2011 | US20110086801 Prevention and reduction of blood loss |
| 04/14/2011 | US20110086798 Erythropoietin compositions |
| 04/14/2011 | US20110086771 Biochip |
| 04/14/2011 | US20110086767 Mutants of glycoside hydrolases and uses thereof for synthesizing complex oligosaccharides and disaccharide intermediates |
| 04/14/2011 | US20110086765 Gene expression profiling of primary breast carcinomas using arrays of candidate genes |
| 04/14/2011 | US20110086425 DELIVERY OF siRNAs |
| 04/14/2011 | US20110086416 Immunotoxin fusion proteins and means for expression thereof |
| 04/14/2011 | US20110086412 Multiply-Substituted Protease Variants |
| 04/14/2011 | US20110086410 BGL4 Beta-Glucosidase and Nucleic Acids Encoding the Same |
| 04/14/2011 | US20110086396 D-amino acid oxidase, and method for production of l-amino acid, 2-oxo acid, or cyclic imine |
| 04/14/2011 | US20110086395 Novel microorganism and its use in lignocellulose detoxification |
| 04/14/2011 | US20110086391 Expression Vector |
| 04/14/2011 | US20110086390 Product and Process for Transformation of Thraustochytriales Microorganisms |
| 04/14/2011 | US20110086387 Mutant nanoarchaeum equitans a523r dna polymerase and its use |
| 04/14/2011 | US20110086367 Pharmaceuticals for influencing the reaction of the human immune system |
| 04/14/2011 | US20110086357 Methods for Evaluating a Disease Condition by Nucleic Acid Detection and Fractionation |
| 04/14/2011 | US20110086345 Isolation and use of ryanodine receptors |
| 04/14/2011 | US20110086342 Hepatocellular Carcinoma-Associated Gene |
| 04/14/2011 | US20110086133 Use of pectinolytic enzymes for the treatment of fruit and vegetable mash and enzyme sequences therefor |
| 04/14/2011 | US20110086132 Transgenic plant expressing maltogenic alpha-amylase |
| 04/14/2011 | US20110086105 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 04/14/2011 | US20110086090 Vectors Containing the Max Gene |
| 04/14/2011 | US20110086072 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/14/2011 | US20110086065 Lentival Vector-Based Vaccine |
| 04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 04/14/2011 | US20110086063 Vaccines for prevention and treatment of addiction |
| 04/14/2011 | US20110086059 Non-hemolytic clya for excretion of proteins |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086056 Methods for the early diagnosis of ovarian cancer |
| 04/14/2011 | US20110086054 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086042 Centrosomal Proteins, Nucleic Acids and Method of Use Thereof |
| 04/14/2011 | US20110086041 Fusion-Intermediate State of HIV-1 gP41 Targeted by Broadly Neutralizing Antibodies |
| 04/14/2011 | US20110086036 Composition comprising vlp and amyloid beta peptide |
| 04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
| 04/14/2011 | US20110086026 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 04/14/2011 | US20110086015 Zinc finger nuclease for the cftr gene and methods of use thereof |
| 04/14/2011 | US20110086013 Acylglycerol acetyltransferase-like protein mgat-x1 and uses thereof |
| 04/14/2011 | US20110086009 Cell line for the production of prostacyclin and uses thereof |
| 04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
| 04/14/2011 | DE112009001385T5 Fettsäure-Dehydratasen und Anwendungen davon Fatty acid dehydratase and applications thereof |
| 04/14/2011 | DE112009000148T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation |
| 04/14/2011 | CA2777222A1 Il-17 family cytokine compositions and uses |
| 04/14/2011 | CA2777198A1 Use of toll-like receptor and agonist for treating cancer |
| 04/14/2011 | CA2777096A1 Compositions and methods for the transport of therapeutic agents |
| 04/14/2011 | CA2777053A1 Human single-chain t cell receptors |
| 04/14/2011 | CA2776969A1 Expression system |
| 04/14/2011 | CA2776954A1 Combinatorial libraries based on c-type lectin domain |
| 04/14/2011 | CA2776922A1 Vaccines comprising heat-sensitive transgenes |
| 04/14/2011 | CA2776874A1 Chaperonin 10 variants |
| 04/14/2011 | CA2776834A1 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing |
| 04/14/2011 | CA2776748A1 Use of pedf in an encapsulated cell-based delivery system |
| 04/14/2011 | CA2776385A1 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
| 04/14/2011 | CA2776126A1 Compositions and methods for promoting fatty acid production in plants |
| 04/14/2011 | CA2775765A1 High affinity adaptor molecules for redirecting antibody specifity |
| 04/14/2011 | CA2775567A1 Transgenic plants having enhanced biomass composition |
| 04/14/2011 | CA2774953A1 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
| 04/14/2011 | CA2774941A1 Generation of haploid plants and improved plant breeding |
| 04/14/2011 | CA2774734A1 A cytolytic rtx-toxin from gallibacterium anatis |
| 04/14/2011 | CA2767924A1 Generation of a broad t-cell response in humans against hiv |
| 04/13/2011 | EP2309272A1 Module-based vector useful in the assessment of antigen-specific T cell functions |
| 04/13/2011 | EP2309264A1 Device for detection of influenza virus |
| 04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 04/13/2011 | EP2308997A2 Detection of nucleic acids by type-specific hybrid capture method |
| 04/13/2011 | EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis |
| 04/13/2011 | EP2308994A1 Methods for determining a risk to develop cancer |
| 04/13/2011 | EP2308987A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 04/13/2011 | EP2308986A1 Artificial plant minichromosomes |
| 04/13/2011 | EP2308985A2 Plastid genetic engineering via somatic embryogenesis |
| 04/13/2011 | EP2308984A1 Embryo sac-specific genes |
| 04/13/2011 | EP2308983A1 Cytochrome P450 from Rhizopus oryzae and uses thereof |
| 04/13/2011 | EP2308982A1 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 04/13/2011 | EP2308981A1 Streptococcal C5a peptidase vaccine |
| 04/13/2011 | EP2308980A2 Alpha-amylase mutants with altered properties |
| 04/13/2011 | EP2308979A2 Alpha-amylase mutants with altered properties |
| 04/13/2011 | EP2308978A1 Luciferase biosensor |
| 04/13/2011 | EP2308977A2 Novel herbicide resistance gene |
| 04/13/2011 | EP2308976A2 Novel herbicide resistance gene |
| 04/13/2011 | EP2308975A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 04/13/2011 | EP2308974A2 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 04/13/2011 | EP2308973A1 Method to screen phage display libraries with different ligands |
| 04/13/2011 | EP2308972A1 Non-destructive procedure for the isolation of DNA from plants |
| 04/13/2011 | EP2308971A1 Compositions and methods for control of insect infestations in plants |
| 04/13/2011 | EP2308970A1 Antibiotic compositions, methods for providing the same and Streptomyces coelicolor mutants for use in such methods |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308966A1 Protease variants |
| 04/13/2011 | EP2308961A2 Tubulin regulatory elements for use in plants |
| 04/13/2011 | EP2308959A1 Novel microorganism and its use in lignocellulose detoxifixcation |
| 04/13/2011 | EP2308899A1 Antibody complex, antigen detection method, and method for production of antibody complex |
| 04/13/2011 | EP2308893A1 Potassium channel mutants of S. cerevisiae and their use for the screening of eucaryotic potassium channels |
| 04/13/2011 | EP2308892A1 Use of siRNA targetting Sipa1l1 for the reduction of adipogenesis |
| 04/13/2011 | EP2308890A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |